Corbett, Christopher J.
Frenzel Sulyok, Lydia G.
Predina, Jarrod D.
Newton, Andrew D.
Bryski, Mitchell G.
Xia, Leilei
Stadanlick, Jason
Shin, Michael H.
Mahalingam, Sakkarapalayam M.
Low, Philip S.
Singhal, Sunil
Funding for this research was provided by:
National Center for Advancing Translational Sciences of the NIH (TL1TR001880)
National Institutes of Health Biomedical Research Partnership (R01 CA193556)
National Institutes of Health Biomedical Research Partnership (R01 CA193556)
Article History
First Online: 9 December 2019
Compliance with ethical standards
:
: Philip Low is on the Board of Directors at On Target Laboratories, the manufacturers of all the study drugs utilized in this report. The remaining authors declare that they have no conflict of interest.